Open House Biologics Discount Agreements 2025-02 - Rituximab (Subcutaneous Injection Dosage Form)

  Address - Germany

  Contact details - 565656565

  Tender notice no. - 76454545

  GT Ref Id - 102163331

  Document Type - Tender Notices

Description - Description: The participating health insurance companies aim to conclude discount agreements with all suitable pharmaceutical companies in accordance with Section 130a Paragraph 8 of the Social Security Code (SGB V) for the active ingredient Rituxim ab (form of administration for subcutaneous injection). The contract is concluded as part of the open house biologics procedure of the participating health insurance companies:local title:: Open-House-Biologika-Rabattverträge 2025-02 - Rituximab (Darreichungsform zur subkutanen Injektion)local description: : Die beteiligten Kassen verfolgen das Ziel, mit allen geeigneten pharmazeutischen Unternehmern Rabattverträge nach § 130a Abs. 8 SGB V zu

Gt Ref Id - 102163331

Deadline - Feb 28, 2027